Zepbound versus Wegovy
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Zepbound versus Wegovy
-
Narrated by:
-
By:
About this listen
- Tirzepatide is more effective for weight loss than semaglutide.
- Cost-effectiveness is crucial in prescribing weight loss medications.
- Patients with severe obesity should receive more expensive medications for better outcomes.
- Both medications show significant benefits for obesity-related conditions.
- Long-term studies indicate sustained weight loss with both drugs.
- Gender differences affect weight loss outcomes with these medications.
- Safety profiles show tirzepatide may be better tolerated than semaglutide.
- The need for affordable drug pricing is emphasized.
- Clinical benefits extend beyond weight loss to include metabolic health.
- Future studies are needed to confirm cardiovascular benefits of tirzepatide.
Click here to see the study
Click here to join Dr. Spencer's new online clinic
What listeners say about Zepbound versus Wegovy
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.